Overview: This page contains the latest trade data of Unpackaged Medicaments. In 2019, Unpackaged Medicaments were the world's 290th most traded product, with a total trade of $11.5B. Between 2018 and 2019 the exports of Unpackaged Medicaments decreased by -36.1%, from $18B to $11.5B. Trade in Unpackaged Medicaments represent 0.063% of total world trade.
Exports: In 2019 the top exporters of Unpackaged Medicaments were Netherlands ($2.38B), United States ($1.27B), Germany ($797M), China ($768M), and Switzerland ($635M).
Imports: In 2019 the top importers of Unpackaged Medicaments were United Kingdom ($2.34B), Ireland ($1.32B), Germany ($803M), United States ($631M), and Netherlands ($473M).
Tariffs: In 2018 the average tariff for Unpackaged Medicaments was 3.99%, making it the 997th lowest tariff using the HS4 product classification.
The countries with the highest import tariffs for Unpackaged Medicaments are Iran (34.5%), Nepal (14.1%), Morocco (11.6%), Pakistan (10.8%), and Tunisia (10%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Ghana (0%), Guinea (0%), and Kenya (0%).
Ranking: Unpackaged Medicaments ranks 383rd in the Product Complexity Index (PCI).
Description: Examples of medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses are antibiotics, which are used to treat bacterial infections, and vaccines, which are used to prevent diseases.